INSMED Inc (INSM) stock
INSMNasdaqPharmaceutical PreparationsFiscal year ends December 31
Financials through Q3 FY2026, quarter ended Sep 30, 2026Last filing: 10-Q on Oct 29, 2026Score 8/3099% above fair value
$121.86−1.02 (-0.83%)
Close on Nov 17, 2026Market cap $26.73BP/E –Yield –
Insmed price to book ratio
The price-to-book ratio is market cap divided by shareholders' equity.
Insmed's price to book ratio was 34.8× on Nov 11, 2026, against 46.7× a year earlier. Over the last 5 years it ranged from 5.3× to 328.3×, with a median of 27.8×.
Price to Book Ratio at the end of each year
| Period | Period end | Value | Change (pts) |
|---|---|---|---|
| 2026 | Nov 11, 2026 | 34.8× | −4.3 |
| 2025 | Dec 31, 2025 | 39.1× | +13.6 |
| 2024 | Dec 31, 2024 | 25.5× | −4.5 |
| 2023 | Apr 28, 2023 | 30.1× | −16.9 |
| 2022 | Oct 31, 2022 | 46.9× | +40.5 |
| 2021 | Dec 31, 2021 | 6.4× | −3.1 |
| 2020 | Dec 31, 2020 | 9.5× | +2.5 |
| 2019 | Dec 31, 2019 | 7.0× | +3.5 |
| 2018 | Dec 31, 2018 | 3.5× | −2.2 |
| 2017 | Dec 29, 2017 | 5.7× | +1.9 |
| 2016 | Dec 30, 2016 | 3.8× | +0.4 |
| 2015 | Dec 31, 2015 | 3.3× | −0.5 |
| 2014 | Dec 31, 2014 | 3.9× | −0.4 |
| 2013 | Dec 31, 2013 | 4.2× | +2.7 |
| 2012 | Dec 31, 2012 | 1.5× | +1.0 |
| 2011 | Dec 30, 2011 | 0.5× | +0.5 |
| 2010 | Dec 31, 2010 | 0.0× | – |
See a number that looks wrong?